| Financial Year |
March 31 2023 |
| Monetary Funds |
100,544,241.35 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
290,227,913.83 |
| Advances to Suppliers |
6,036,859.86 |
| Other Receivables |
7,075,734.17 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
224,540,139.01 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
7,860,357.31 |
| Total Current Assets |
636,285,245.53 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
82,441,917.96 |
| Fixed Assetes |
1,062,257,158.34 |
| Under-construction Projects |
9,793,086.52 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
113,273,891.36 |
| R&D expenses |
8,051,457.92 |
| Goodwill |
4,173,809.58 |
| Long-Term Deferred and Prepaid Expenses |
6,652,188.26 |
| Deferred Income Tax Assets |
6,741,440.26 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,399,132,218.19 |
| Total Assets |
2,035,417,463.72 |
| Short-Term Loans |
419,082,042.13 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
200,469,377.41 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
16,758,401.47 |
| Taxes Payable |
13,128,482.68 |
| Interest Payable |
96,666,186.11 |
| Dividend Payable |
-- |
| Other payables |
988,727,786.41 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
9,918,152.26 |
| Other Current Liabilities |
18,068.16 |
| Sub-Total of Current Liabilities |
1,654,322,527.73 |
| Long-term Loans |
27,650,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
13,063,660.03 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,275,515,650.34 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,524,248,164.59 |
| Total Liabilities |
3,178,570,692.32 |
| Paid-In Capital(Or Share Stock) |
756,350,000.00 |
| Capital Surplus |
2,074,545,988.38 |
| Surplus Reserve |
83,499,084.58 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-4,077,025,645.81 |
| Minority Stockholder's Interest |
14,044,090.14 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-1,157,197,318.74 |
| Owner's Equity（Stockholder's Equity） |
-1,143,153,228.60 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,035,417,463.72 |
